Advertisement

Breast Cancer Research and Treatment

, Volume 94, Issue 2, pp 145–152 | Cite as

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

  • Paula Maguire
  • Sara Margolin
  • Johanna Skoglund
  • Xiao-Feng Sun
  • Jan-Åke Gustafsson
  • Anne-Lise Børresen-Dale
  • Annika LindblomEmail author
Report

Summary

Estrogen is involved in both normal mammary development and in breast carcinogenesis. A family history of disease and exposure to estrogen are major risk factors for developing breast cancer. Estrogen exerts its biological effects through binding to the estrogen receptors, estrogen receptor alpha (ESR1) and the more recently discovered estrogen receptor beta (ESR2). Genetic variation in genes involved in estrogen biosynthesis, metabolism and signal transduction have been suggested to play a role in breast cancer risk. We therefore tested the hypothesis that common genetic variants of the ESR2 gene may be associated with increased risk for breast cancer and this risk may vary between breast cancer groups. We investigated three common ESR2 polymorphisms, rs1256049 (G1082A), rs4986938 (G1730A) and rs928554 (Cx+56 A→G) for association to breast cancer risk. A total of 723 breast cancer cases and 480 controls were included in the study. Of the breast cancer cases, 323 were sporadic and 400 were familial, the familial cases were further divided into familial high-risk and familial low-risk breast cancer cases. We found no overall statistically significant association for any of the single polymorphisms studied. Haplotype analysis suggested one haplotype associated with increased risk in sporadic breast cancer patients (OR = 3.0, = 0.03). Further analysis is needed to elucidate the role of estrogen receptor beta in breast cancer susceptibility.

Keywords

association breast cancer estrogen receptor beta ESR2 familial breast cancer haplotype polymorphism sporadic breast cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Miki, Y, Swensen, J, Shattuck-Eidens, D, Futreal, PA, Harshman, K, Tavtigian, S, Liu, Q, Cochran, C, Bennett, LM, Ding, W 1994A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1Science2666671PubMedGoogle Scholar
  2. 2.
    Wooster, R, Neuhausen, SL, Mangion, J, Quirk, Y, Ford, D, Collins, N, Nguyen, K, Seal, S, Tran, T, Averill, D 1994Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13Science26520882090PubMedGoogle Scholar
  3. 3.
    Pharoah, PD, Antoniou, A, Bobrow, M, Zimmern, RL, Easton, DF, Ponder, BA 2002Polygenic susceptibility to breast cancer and implications for preventionNat Genet313336CrossRefPubMedGoogle Scholar
  4. 4.
    Martin, AM, Weber, BL 2000Genetic and hormonal risk factors in breast cancerJ Natl Cancer Inst9211261135CrossRefPubMedGoogle Scholar
  5. 5.
    Green, S, Walter, P, Kumar, V, Krust, A, Bornert, JM, Argos, P, Chambon, P 1986Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature320134139CrossRefPubMedGoogle Scholar
  6. 6.
    Greene, GL, Gilna, P, Waterfield, M, Baker, A, Hort, Y, Shine, J 1986Sequence and expression of human estrogen receptor complementary DNAScience23111501154PubMedGoogle Scholar
  7. 7.
    Mosselman, S, Polman, J, Dijkema, R 1996ER beta: identification and characterization of a novel human estrogen receptorFEBS Lett3924953CrossRefPubMedGoogle Scholar
  8. 8.
    Kuiper, GG, Enmark, E, Pelto-Huikko, M, Nilsson, S, Gustafsson, JA 1996Cloning of a novel receptor expressed in rat prostate and ovaryProc Natl Acad Sci USA9359255930CrossRefPubMedGoogle Scholar
  9. 9.
    Zhang, QX, Borg, A, Fuqua, SA 1993An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancerCancer Res5358825884PubMedGoogle Scholar
  10. 10.
    Inoue, S, Hoshino, S, Miyoshi, H, Akishita, M, Hosoi, T, Orimo, H, Ouchi, Y 1996Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cellsBiochem Biophys Res Commun219766772CrossRefPubMedGoogle Scholar
  11. 11.
    Ogawa, S, Inoue, S, Watanabe, T, Orimo, A, Hosoi, T, Ouchi, Y, Muramatsu, M 1998Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in humanNucleic Acids Res2635053512CrossRefPubMedGoogle Scholar
  12. 12.
    Ogawa, S, Inoue, S, Watanabe, T, Hiroi, H, Orimo, A, Hosoi, T, Ouchi, Y, Muramatsu, M 1998The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitroBiochem Biophys Res Commun243122126CrossRefPubMedGoogle Scholar
  13. 13.
    Leygue, E, Dotzlaw, H, Watson, PH, Murphy, LC 1999Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissueCancer Res5911751179PubMedGoogle Scholar
  14. 14.
    Palmieri, C, Cheng, GJ, Saji, S, Zelada-Hedman, M, Warri, A, Weihua, Z, Noorden, S, Wahlstrom, T, Coombes, RC, Warner, M 2002Estrogen receptor beta in breast cancerEndocr Relat Cancer9113CrossRefPubMedGoogle Scholar
  15. 15.
    Iwao, K, Miyoshi, Y, Egawa, C, Ikeda, N, Noguchi, S 2000Quantitative analysis of estrogen receptor-beta mRNA and its variants in human breast cancersInt J Cancer88733736CrossRefPubMedGoogle Scholar
  16. 16.
    Zhao, C, Lam, EW, Sunters, A, Enmark, E, Bella, MT, Coombes, RC, Gustafsson, JA, Dahlman-Wright, K 2003Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylationOncogene2276007606CrossRefPubMedGoogle Scholar
  17. 17.
    Leygue, E, Dotzlaw, H, Watson, PH, Murphy, LC 1998Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesisCancer Res5831973201PubMedGoogle Scholar
  18. 18.
    Dunning, AM, Healey, CS, Pharoah, PD, Teare, MD, Ponder, BA, Easton, DF 1999A systematic review of genetic polymorphisms and breast cancer riskCancer Epidemiol Biomarkers Prev8843854PubMedGoogle Scholar
  19. 19.
    Forsti, A, Zhao, C, Israelsson, E, Dahlman-Wright, K, Gustafsson, JA, Hemminki, K 2003Polymorphisms in the estrogen receptor beta gene and risk of breast cancer: no associationBreast Cancer Res Treat79409413CrossRefPubMedGoogle Scholar
  20. 20.
    Zheng, SL, Zheng, W, Chang, BL, Shu, XO, Cai, Q, Yu, H, Dai, Q, Xu, J, Gao, YT 2003Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese womenCancer Res6376247629PubMedGoogle Scholar
  21. 21.
    Gold, B, Kalush, F, Bergeron, J, Scott, K, Mitra, N, Wilson, K, Ellis, N, Huang, H, Chen, M, Lippert, R 2004Estrogen receptor genotypes and haplotypes associated with breast cancer riskCancer Res6488918900CrossRefPubMedGoogle Scholar
  22. 22.
    Rosenkranz, K, Hinney, A, Ziegler, A, Hermann, H, Fichter, M, Mayer, H, Siegfried, W, Young, JK, Remschmidt, H, Hebebrand, J 1998Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variantsJ Clin Endocrinol Metab8345244527CrossRefPubMedGoogle Scholar
  23. 23.
    Nilsson, M, Naessen, S, Dahlman, I, Linden Hirschberg, A, Gustafsson, JA, Dahlman-Wright, K 2004Association of estrogen receptor beta gene polymorphisms with bulimic disease in womenMol Psychiatry92834CrossRefPubMedGoogle Scholar
  24. 24.
    Claus, EB, Schildkraut, JM, Thompson, WD, Risch, NJ 1996The genetic attributable risk of breast and ovarian cancerCancer7723182324CrossRefPubMedGoogle Scholar
  25. 25.
    Gail, MH, Brinton, LA, Byar, DP, Corle, DK, Green, SB, Schairer, C, Mulvihill, JJ 1989Projecting individualized probabilities of developing breast cancer for white females who are being examined annuallyJ Natl Cancer Inst8118791886PubMedGoogle Scholar
  26. 26.
    Margolin, S, Werelius, B, Fornander, T, Lindblom, A 2004BRCA1 mutations in a population-based study of breast cancer in Stockholm CountyGenet Test8127132PubMedGoogle Scholar
  27. 27.
    Barrett, JC, Fry, B, Maller, J, Daly, MJ 2005Haploview: analysis and visualization of LD and haplotype mapsBioinformatics21263265CrossRefPubMedGoogle Scholar
  28. 28.
    Dudbridge, F 2003Pedigree disequilibrium tests for multilocus haplotypesGenet Epidemiol25115121CrossRefPubMedGoogle Scholar
  29. 29.
    Gabriel, SB, Schaffner, SF, Nguyen, H, Moore, JM, Roy, J, Blumenstiel, B, Higgins, J, DeFelice, M, Lochner, A, Faggart, M 2002The structure of haplotype blocks in the human genomeScience29622252229CrossRefPubMedGoogle Scholar
  30. 30.
    Inoue, S, Ogawa, S, Horie, K, Hoshino, S, Goto, W, Hosoi, T, Tsutsumi, O, Muramatsu, M, Ouchi, Y 2000An estrogen receptor beta isoform that lacks exon 5 has dominant negative activity on both ERalpha and ERbetaBiochem Biophys Res Commun279814819CrossRefPubMedGoogle Scholar
  31. 31.
    Tong, D, Schuster, E, Seifert, M, Czerwenka, K, Leodolte, S, Zeillinger, R 2002Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell linesBreast Cancer Res Treat71249255CrossRefPubMedGoogle Scholar
  32. 32.
    Omoto, Y, Kobayashi, S, Inoue, S, Ogawa, S, Toyama, T, Yamashita, H, Muramatsu, M, Gustafsson, JA, Iwase, H 2002Evaluation of oestrogen receptor beta wild-type and variant protein expression, and relationship with clinicopathological factors in breast cancersEur J Cancer38380386CrossRefPubMedGoogle Scholar
  33. 33.
    Poola, I, Abraham, J, Liu, A 2002Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesisJ Steroid Biochem Mol Biol82169179CrossRefPubMedGoogle Scholar
  34. 34.
    Palmieri, C, Saji, S, Sakaguchi, H, Cheng, G, Sunters, A, O’Hare, MJ, Warner, M, Gustafsson, JA, Coombes, RC, Lam, EW 2004The expression of oestrogen receptor (ER)-beta and its variants, but not ERalpha, in adult human mammary fibroblastsJ Mol Endocrinol333550CrossRefPubMedGoogle Scholar
  35. 35.
    Girault, I, Andrieu, C, Tozlu, S, Spyratos, F, Bieche, I, Lidereau, R 2004Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinomaCancer Lett215101112CrossRefPubMedGoogle Scholar
  36. 36.
    Sundarrajan, C, Liao, WX, Roy, AC, Ng, SC 2001Association between estrogen receptor-beta gene polymorphisms and ovulatory dysfunctions in patients with menstrual disordersJ Clin Endocrinol Metab86135139CrossRefPubMedGoogle Scholar
  37. 37.
    Ogawa, S, Hosoi, T, Shiraki, M, Orimo, H, Emi, M, Muramatsu, M, Ouchi, Y, Inoue, S 2000Association of estrogen receptor beta gene polymorphism with bone mineral densityBiochem Biophys Res Commun269537541CrossRefPubMedGoogle Scholar
  38. 38.
    Setiawan VW, Hankinson SE, Colditz GA, Hunter DJ, Vivo ID: Estrogen receptor beta (ESR2) polymorphisms and endometrial cancer (United States) Cancer Causes Control 15: 627–633, 2004Google Scholar
  39. 39.
    Garte, S, Gaspari, L, Alexandrie, AK, Ambrosone, C, Autrup, H, Autrup, JL, Baranova, H, Bathum, L, Benhamou, S, Boffetta, P 2001Metabolic gene polymorphism frequencies in control populationsCancer Epidemiol Biomarkers Prev1012391248PubMedGoogle Scholar
  40. 40.
    Hemminki, K, Forsti, A 2002Proper controls for SNP studies?Carcinogenesis2314051406CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Paula Maguire
    • 1
  • Sara Margolin
    • 2
  • Johanna Skoglund
    • 1
  • Xiao-Feng Sun
    • 3
  • Jan-Åke Gustafsson
    • 4
  • Anne-Lise Børresen-Dale
    • 5
  • Annika Lindblom
    • 1
    Email author
  1. 1.Department of Molecular MedicineKarolinska InstituteStockholmSweden
  2. 2.Department of OncologyKarolinska University HospitalStockholmSweden
  3. 3.Department of OncologyUniversity HospitalLinköpingSweden
  4. 4.Department of Medical NutritionKarolinska InstituteNovumSweden
  5. 5.Department of Genetics, The Norwegian Radium HospitalUniversity of OsloMontebelloNorway

Personalised recommendations